DCT
1:23-cv-01332
AbbVie Inc v. Aurobindo Pharma USA Inc
General
Filed
11/20/23
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
PACER
1:23-cv-01332
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
11/22/23 - 09/12/25 | 45% |
Magistrate
Sherry R. Fallon
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L4 D | |
L2 B | |
L2 C | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L4 B | |
L5 E | |
L3 A | |
L3 D | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L4 E | |
L4 E | |
L4 E | |
L4 E | |
-- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 C | |
L3 D | |
L3 E | |
L3 E | |
L2 B | |
L2 E | |
L1 A | |
-- -- -- | |
L5 E | |
L5 C | |
L3 D | |
L2 B | |
-- -- -- | |
-- -- -- | |
L4 D | |
L4 A | |
L4 E | |
L1 D | |
-- -- -- | |
Morris James LLPLocal | L4 E |
L5 E | |
L3 E | |
L4 E | |
L2 E | |
L5 E | |
L4 E | |
L4 E | |
L4 E |
No Attorneys